Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
79.65198
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
20,446
13,634.6875
13,886.8672
20.5
white
23.199219
46
0.721924
0.635986
5
1
0
no
null
null
no dnr
8
111
null
74
12
35.69531
293.3125
null
null
2
137
7.65918
114
46
null
null
0
no(M2 and SIP pres)
0
817
0
76.79395
male
0
9
COPD
COPD/CHF/Cirrhosis
2
null
null
0
6,728
4,467.4805
4,173.90625
8
white
21.5
29
0.781982
0.650879
1
0
0
no
0.95
0.9
dnr after sadm
2
82
3.799805
77
20
36.29688
null
4.199219
0.699951
1.099854
138
null
138
18
5,150
null
null
null
3.375977
473
1
85.88898
female
0
7
Coma
Coma
0
16
$11-$25k
89
34,805
24,401.1719
25,418.6875
22.5
white
20.898438
28
0.077988
0.043999
12
0
0
no
0.02
0
dnr after sadm
3
66
8.298828
56
28
36
221.71875
4.299805
1.099854
0.899902
137
7.329102
168
15
1,700
null
0
<2 mo. follow-up
0
15
1
35.15399
male
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
null
94
100,043
66,069.8125
63,446.2812
32.666657
white
16.199219
37
0.716919
0.630981
12
0
0
no
0.8
0.75
no dnr
22
126
14.199219
132
10
39.29688
154
2.199707
1.899902
1
135
7.389648
235
17
2,785
null
0
adl>=4 (>=5 if sur)
0
811
0
46.57599
female
0
37
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
100,646
68,337.125
66,688.625
35
white
39.5
60
0.588989
0.47998
1
0
0
no
0.9
0.9
no dnr
37
43
10.599609
0
0
38.39844
133.3125
null
1.399902
2.5
132
7.379883
345
38
1,300
null
null
null
2.007813
811
0
68.38898
female
0
15
COPD
COPD/CHF/Cirrhosis
5
11
null
0
26,261
17,221.2969
17,921.8438
11.666664
white
17.296875
17
0.846924
0.747925
1
0
0
yes
1
1
no dnr
15
78
7
83
20
35.89844
323.75
3.899902
0.899902
1.899902
143
7.519531
95
39
1,975
1
0
no(M2 and SIP pres)
0
808
0
78.29999
male
1
154
COPD
COPD/CHF/Cirrhosis
1
null
null
0
245,741
169,825.875
192,487.5
24.25
white
32.695313
39
0.522949
0.322998
1
0
0
no
0.8
0.6
dnr after sadm
133
70
5.899414
54
22
35.89844
295.1875
null
null
2.099609
143
7.419922
98
48
1,700
null
1
Coma or Intub
1
154
1
73.89697
female
1
42
COPD
COPD/CHF/Cirrhosis
1
10
under $11k
44
84,535
57,884.5625
64,970.9688
28.75
white
27
35
0.519897
0.319946
1
0
0
no
0.5
0.5
dnr after sadm
40
53
null
105
10
38.79688
87.04688
2.899902
1.399902
2.799805
132
7.5
169
68
1,898
null
1
<2 mo. follow-up
1
42
1
38.90799
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
46,452
32,660.1562
37,199.125
22
white
28
47
0.795898
0.728882
1
1
0
yes
0.75
0.75
no dnr
22
81
10.099609
74
22
35.79688
null
3.599609
2.899902
1.099854
125
null
111
9
null
null
1
null
1
808
0
78.18994
male
0
3
CHF
COPD/CHF/Cirrhosis
2
null
null
0
2,297
1,613.8281
1,369.46973
null
white
19.296875
22
0.828979
0.720947
1
0
0
no
0.5
0.2
no dnr
3
122
8.199219
87
24
35.89844
133.3125
4.599609
0.599976
0.699951
142
7.339844
113
11
null
null
null
null
2.075684
126
1
32.13397
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
null
0
9,885
6,642.668
6,093.61719
13
white
14.199219
21
0.949951
0.930908
1
1
0
no
0.99
0.99
no dnr
11
119
11.599609
67
16
36.09375
null
2.299805
0.399963
1.799805
137
null
240
26
1,425
1
1
null
1
803
0
38.25098
male
0
33
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
0
47,539
31,000.7188
33,095.0312
8.25
white
23.699219
43
0.8479
0.750977
1
0
0
no
0.95
0.95
no dnr
33
111
8.699219
122
24
37.89844
252.375
null
0.399963
1.5
134
7.429688
124
20
2,000
null
null
no(M2 and SIP pres)
2.790527
804
0
56.46298
male
0
3
Lung Cancer
Cancer
1
12
null
0
3,338
2,026.9092
1,108.2793
null
white
14
5
0.778931
0.53894
1
0
0
metastatic
0.9
0.6
no dnr
3
63
3.299805
130
9
39.29688
155
2.699707
2.299805
0.799927
133
7.419922
94
9
5,025
null
null
null
1.932861
142
1
63.24197
female
0
8
COPD
COPD/CHF/Cirrhosis
7
12
null
0
6,430
4,216.7852
3,579.25977
9.5
white
27.398438
42
0.778931
0.645996
1
1
0
no
1
1
no dnr
8
72
null
53
22
36.19531
null
null
null
1
137
null
90
17
2,250
0
1
no(M2 and SIP pres)
1
801
0
43.21698
female
0
11
Lung Cancer
Cancer
1
13
>$50k
0
18,964
12,439.8594
11,921.0938
12
white
14.5
18
0.794922
0.566895
1
0
0
metastatic
0.6
0.1
no dnr
11
75
16.699219
120
12
36.19531
210
2.5
1.799805
0.799927
138
7.449219
179
39
1,200
0
0
no(M2 and SIP pres)
0
492
1
59.74298
male
0
3
Lung Cancer
Cancer
2
14
$25-$50k
0
4,125
2,489.4258
1,088.78906
null
white
15.599609
2
0.746948
0.484985
1
0
0
metastatic
0.8
0.5
no dnr
3
69
21.097656
130
44
39.09375
108.875
2.599609
null
0.699951
142
7.459961
249
14
1,575
0
null
no(M2 and SIP pres)
0.494751
163
1
69.46698
female
0
5
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,184
2,792.2969
2,522.36914
15
white
18.597656
13
0.862915
0.773926
1
1
0
no
0.9
0.8
no dnr
5
72
9.5
79
22
36.59375
null
null
null
0.899902
140
null
113
25
null
0
0
null
0
796
0
83.25494
female
0
4
CHF
COPD/CHF/Cirrhosis
0
16
$11-$25k
0
2,127
1,396.165
1,228.50977
11
white
20.5
56
0.791992
0.665894
1
0
0
no
null
null
dnr before sadm
-1
72
null
104
40
38.09375
222.84375
3
0.599976
0.799927
134
7.469727
154
17
1,200
0
null
no(M2 and SIP pres)
0.494751
337
1
74.41199
male
0
9
CHF
COPD/CHF/Cirrhosis
4
12
null
0
5,954
4,052.7539
3,623.86914
5.5
white
21.898438
35
0.707886
0.547974
1
1
0
metastatic
null
null
dnr after sadm
1
80
4.799805
81
24
36.5
480.9375
2.099609
8.199219
1.699951
133
7.40918
127
28
1,600
1
1
no(M2 and SIP pres)
1
667
1
69.68396
male
1
4
COPD
COPD/CHF/Cirrhosis
4
12
$25-$50k
37
33,100
21,796.5625
20,146.1562
63
white
40.59375
62
0.212982
0.067993
1
1
0
no
0.5
0.5
no dnr
4
105
null
101
48
36.09375
181.46875
null
null
null
140
7.359375
null
null
48
null
null
<2 mo. follow-up
3.724609
4
1
58.85797
female
0
109
Coma
Coma
1
10
null
55
116,164
109,721.812
119,173.688
29.5
white
19.796875
23
0.511963
0.440979
12
1
0
no
0.75
0.75
no dnr
109
81
9.099609
63
24
35.89844
null
null
0.5
1
128
null
257
10
2,450
null
0
null
0
130
1
84.27698
male
1
5
COPD
COPD/CHF/Cirrhosis
3
13
under $11k
0
5,460
3,369.4941
3,020.37891
18
white
24.5
35
0.665894
0.491943
1
0
0
no
null
null
dnr before sadm
-1
60
3.699707
150
42
38.79688
108
2.599609
0.599976
0.699951
137
7.25
160
7
3,950
null
null
<2 mo. follow-up
3.415039
5
1
40.29797
female
0
7
Colon Cancer
Cancer
5
14
$11-$25k
0
5,921
3,866.3652
4,304.56641
8.5
white
21.398438
19
0.80188
0.578979
1
0
0
metastatic
0.6
0.1
no dnr
7
107
13.398438
110
40
38.69531
307.25
2.099609
1
1.399902
145
7.349609
262
46
2,875
null
null
null
2.475098
251
1
86.89899
male
0
7
CHF
COPD/CHF/Cirrhosis
7
8
null
0
5,325
3,531.0039
3,393.24805
5.5
white
19.199219
22
0.75
0.605957
1
1
0
yes
0.98
0.95
dnr after sadm
1
78
5.899414
93
16
36.29688
null
null
null
1.099854
134
null
101
23
3,425
0
0
<2 mo. follow-up
0
23
1
65.49799
female
0
12
Colon Cancer
Cancer
1
12
$25-$50k
0
16,509
10,621.1328
11,741.8984
17
white
14.099609
11
0.851929
0.671997
1
0
0
metastatic
0.9
0.5
no dnr
12
69
9.199219
69
24
35.59375
193.3125
null
0.599976
1.099854
151
7.25
97
19
null
2
1
no(M2 and SIP pres)
1
174
1
74.08899
female
0
13
COPD
COPD/CHF/Cirrhosis
3
8
null
0
13,953
8,987.8828
8,930.65625
13.5
white
20.898438
31
0.806885
0.687988
1
1
0
no
0.9
0.8
dnr after sadm
2
61
11.099609
87
24
35.79688
195.90625
null
1.299805
1.5
138
7.359375
153
29
null
2
1
SIP>=30
1
657
1
70.97894
male
0
5
Lung Cancer
Cancer
2
null
null
0
5,531
3,486.9531
3,746.03906
11
white
6
21
0.860962
0.689941
1
0
0
metastatic
0.6
0.3
no dnr
5
83
4.099609
70
20
36.19531
null
3.299805
0.399963
1
132
null
102
17
2,675
null
null
null
2.37793
375
1
73.40997
male
0
12
COPD
COPD/CHF/Cirrhosis
3
8
null
0
12,190
7,729.9258
6,668.78906
9
white
26
44
0.728882
0.575928
1
1
0
no
null
null
dnr after sadm
1
141
3.699707
89
24
36.59375
342.8125
null
0.199982
0.699951
135
7.469727
95
23
1,175
null
4
no(M2 and SIP pres)
4
783
0
65.35498
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
25,070
17,162.6562
17,509.5469
16.333328
white
23.398438
34
0.813965
0.751953
1
1
0
no
0.95
0.8
no dnr
14
111
9.099609
96
24
36.59375
null
2.399902
0.5
2.5
137
null
101
37
2,025
1
0
SIP>=30
0
244
1
81.18298
female
0
6
CHF
COPD/CHF/Cirrhosis
2
8
null
0
3,984
2,696.1523
2,405.09961
9
white
18
19
0.833984
0.728882
1
0
0
no
0.75
0.5
dnr before sadm
-1
62
4.699219
79
20
36.39844
null
3.799805
0.399963
0.899902
134
null
160
5
1,375
2
3
no(M2 and SIP pres)
3
779
0
74.61694
male
0
20
Lung Cancer
Cancer
1
12
$11-$25k
0
12,082
8,386.3984
9,921.57812
7
white
12.398438
21
0.770996
0.524902
1
0
0
metastatic
0.8
0.4
no dnr
20
64
21.699219
136
10
39.09375
182
null
0.699951
1.599854
165
7.489258
535
16
8,150
0
1
no(M2 and SIP pres)
1
90
1
78.85797
female
0
5
Coma
Coma
2
null
null
61
11,071
7,437.3203
9,641.11719
33
white
20.296875
21
0.370972
0.297974
1
0
0
no
null
null
dnr before sadm
-1
64
11
102
36
36.59375
204.75
null
0.899902
2
140
7.40918
91
32
2,595
null
null
<2 mo. follow-up
2.486328
10
1
54.38998
male
0
12
Lung Cancer
Cancer
2
12
under $11k
0
7,294
4,587.8359
4,631.10938
3.5
white
15.199219
20
0.763916
0.513916
1
0
0
metastatic
1
0.95
no dnr
12
70
16.296875
67
34
37.5
148
null
0.399963
0.699951
137
7.30957
157
19
1,475
0
0
<2 mo. follow-up
0
45
1
89.47797
female
0
9
CHF
COPD/CHF/Cirrhosis
6
13
null
0
5,923
3,958.7891
3,650.44922
12.5
white
22.796875
31
0.724976
0.569946
1
0
0
no
0.75
0.25
dnr after sadm
1
69
7.5
104
24
35.89844
320
null
1.399902
1.099854
138
7.5
99
19
null
null
7
adl>=4 (>=5 if sur)
7
319
1
76.74695
male
0
10
CHF
COPD/CHF/Cirrhosis
6
8
under $11k
0
6,191
4,101.8906
3,931.87891
4.5
white
16.296875
14
0.832886
0.727905
1
0
0
yes
0.7
0.5
no dnr
10
77
11.099609
77
24
36.09375
223.78125
4
0.5
1
140
7.429688
120
8
3,740
2
2
SIP>=30
2
211
1
46.702
male
0
6
Coma
Coma
1
12
$25-$50k
0
11,002
7,584.875
9,858.64844
11
white
19.296875
16
0.840942
0.80896
3
0
0
no
0.95
0.95
no dnr
6
71
6
71
24
36.39844
253.84375
null
null
0.799927
141
7.40918
120
10
1,075
0
0
no(M2 and SIP pres)
0
773
0
90.53497
male
0
14
COPD
COPD/CHF/Cirrhosis
3
5
null
0
9,899
6,333.6719
6,989.06641
7.333332
white
19.898438
32
0.705933
0.543945
1
0
0
no
0.8
0.5
dnr before sadm
0
121
16.898438
112
8
38.89844
255
3.899902
0.799927
1.099854
140
7.429688
226
12
2,905
null
1
no(M2 and SIP pres)
1
774
0
80.745
male
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
null
37
8,599
5,789.1133
6,502.00781
31
white
31
40
0.417969
0.29895
1
0
0
no
0.25
0.1
dnr after sadm
1
43
21.699219
104
36
35.59375
168.3125
2.699707
0.399963
0.5
143
7.399414
149
18
805
null
5
<2 mo. follow-up
5
5
1
48.47897
male
0
53
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
9
99,065
66,641.9375
80,853.75
39.25
white
27.898438
40
0.783936
0.713989
1
0
0
no
0.75
0.75
no dnr
53
107
41.898438
112
30
35.79688
91.65625
2.599609
0.799927
6.599609
129
7.439453
202
40
0
null
0
adl>=4 (>=5 if sur)
0
772
0
57.21597
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$11-$25k
0
9,600
6,362.043
7,529.85938
16.5
other
20.898438
32
0.865967
0.819946
1
1
0
no
0.5
0.4
dnr after sadm
3
57
8.298828
60
26
36.09375
304.75
null
null
1.099854
135
7.399414
212
16
2,485
null
7
adl>=4 (>=5 if sur)
7
770
0
70.90796
male
0
4
Lung Cancer
Cancer
2
12
under $11k
0
3,590
2,661.1875
2,430.67969
4
white
13.898438
21
0.75293
0.494995
1
0
0
metastatic
0.5
0.2
dnr after sadm
1
55
16.699219
142
22
39.69531
201.65625
1.699951
2.299805
3
137
7.199219
388
31
null
null
null
<2 mo. follow-up
2.099609
19
1
78.245
male
0
35
Coma
Coma
3
8
null
61
43,459
28,174.9375
31,811.0781
15
white
16.796875
29
0.393982
0.319946
1
0
0
yes
0.7
0.6
dnr after sadm
9
36
42.296875
128
54
38.39844
252.375
2.299805
1.099854
8.599609
129
7.399414
215
120
0
null
1
<2 mo. follow-up
1
50
1
88.375
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
5
under $11k
0
10,371
7,066.0859
7,182.92969
17
white
22.597656
44
0.740967
0.659912
1
0
0
no
0.8
0.75
dnr after sadm
1
63
null
114
38
38.29688
174.28125
1.899902
1.299805
1.399902
142
7.509766
143
49
1,925
null
1
no(M2 and SIP pres)
1
763
0
50.62598
female
0
5
Colon Cancer
Cancer
2
16
>$50k
0
3,827
2,371.9648
1,742.90918
7
white
14.599609
9
0.86792
0.704956
1
0
0
metastatic
0.9
0.5
no dnr
5
141
26.699219
132
24
36.59375
106.65625
null
null
0.899902
133
7.40918
178
20
4,100
0
0
no(M2 and SIP pres)
0
422
1
66.08099
male
0
5
Lung Cancer
Cancer
3
12
>$50k
0
5,742
3,662.0156
2,800.14844
14
white
18.199219
15
0.681885
0.386963
1
0
0
metastatic
0.8
0.6
no dnr
5
79
4.799805
65
18
35.79688
null
4
0.399963
1
138
null
95
16
null
null
null
no(M2 and SIP pres)
2.419434
509
1
65.11395
male
0
7
CHF
COPD/CHF/Cirrhosis
4
12
null
0
7,216
4,896.9844
4,392.24609
12
white
31.597656
57
0.682983
0.513916
1
0
0
no
0.7
0.5
no dnr
7
101
10.699219
60
24
35.39844
208
null
1.299805
1.5
135
7.419922
176
43
1,725
1
1
null
1
77
1
72.534
male
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
$11-$25k
37
26,337
17,738.7656
18,998.2188
34.5
white
19.898438
19
0.707886
0.619995
3
0
0
no
0.8
0.8
no dnr
13
72
7.099609
61
20
36.19531
null
3.299805
0.299988
1.199951
142
null
76
18
1,775
null
1
no(M2 and SIP pres)
1
146
1
76.26294
female
0
30
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
under $11k
0
101,645
65,776.875
74,070
27.5
white
21.296875
24
0.733887
0.650879
32
0
0
no
0.75
0.5
no dnr
30
83
6.299805
89
18
36.79688
null
null
null
0.799927
134
null
98
12
null
null
null
null
1.938965
755
0
79.37299
male
0
11
CHF
COPD/CHF/Cirrhosis
2
8
null
0
7,302
4,651.1211
4,865.4375
10
white
22.199219
31
0.782959
0.652954
1
0
0
no
0.8
0.7
no dnr
11
117
15.599609
79
20
36
null
3.599609
0.299988
1.099854
134
null
141
11
null
0
0
no(M2 and SIP pres)
0
290
1
78.42596
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
19,552
13,048.4062
12,614.1641
20
white
24.296875
38
0.705933
0.616943
5
0
0
no
0.25
0.1
dnr after sadm
2
64
3
40
12
31.69922
null
3
1.899902
1.399902
142
null
98
12
2,390
0
1
no(M2 and SIP pres)
1
750
0
69.56598
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
0
21,123
15,517.9609
14,915.375
12.666664
white
22.796875
57
0.80896
0.744995
1
0
0
no
0.5
0.3
no dnr
19
73
31.796875
122
44
36.69531
145
1.799805
3
2.699707
128
7.449219
95
73
1,098
1
0
no(M2 and SIP pres)
0
276
1
71.20099
male
1
16
Coma
Coma
2
12
null
89
23,547
16,675.1406
17,210.0469
29
white
28.5
66
0.098999
0.058998
1
0
0
no
null
null
dnr after sadm
3
105
8
98
16
36.19531
null
4.099609
0.199982
1.299805
133
null
104
17
3,225
null
0
<2 mo. follow-up
0
16
1
50.93799
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
47,782
31,594.3594
31,824.6562
49
white
26.199219
63
0.809937
0.745972
2
0
0
no
0.8
0.7
no dnr
7
60
10.599609
131
28
36.59375
276.875
null
0.699951
2
133
7.479492
83
49
1,200
null
null
<2 mo. follow-up
2.028809
7
1
54.95398
male
1
36
MOSF w/Malig
ARF/MOSF
3
12
under $11k
0
188,415
120,854.812
145,093.125
34.75
white
36.5
75
0.259949
0.153992
26
0
0
yes
0.8
0.6
dnr after sadm
35
61
3.399902
67
28
34.79688
null
2.399902
11.5
1.099854
139
null
206
66
1,750
null
0
<2 mo. follow-up
0
36
1
92.68195
male
0
5
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
3,435
2,327.6621
2,424.68945
11
white
20.398438
31
0.75293
0.609985
1
0
0
no
0.9
0.6
no dnr
5
68
16.097656
107
24
36.39844
165
4.099609
0.199982
1.199951
132
7.339844
446
42
3,150
0
0
no(M2 and SIP pres)
0
748
0
52.38599
male
0
4
Lung Cancer
Cancer
2
12
$25-$50k
0
3,526
2,257.0606
2,564.62891
10
white
1.199951
19
0.918945
0.809937
1
0
0
metastatic
0.9
0.75
no dnr
4
69
12.199219
64
35
35.69531
133.84375
2.699707
0.799927
0.899902
138
7.449219
168
24
1,375
null
0
no(M2 and SIP pres)
0
120
1
62.004
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
null
44
68,056
47,110.8438
48,286.9062
40
white
37
67
0.227997
0.128998
12
0
0
no
0.1
0.1
no dnr
5
134
10.199219
107
20
36.19531
357.125
null
null
1.599854
131
7.389648
133
25
1,775
null
0
<2 mo. follow-up
0
5
1
59.67697
male
0
12
Lung Cancer
Cancer
2
11
$11-$25k
0
16,618
10,802.1797
11,391.1328
9.5
white
25.296875
30
0.524902
0.201996
1
0
0
metastatic
0.95
0.5
dnr after sadm
10
80
20.097656
81
24
36
278.25
4.299805
0.5
0.799927
133
7.379883
136
11
null
0
0
SIP>=30
0
96
1
45.38498
male
0
59
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
0
129,834
null
null
35.75
white
29.398438
34
0.771973
0.698975
3
0
1
no
0.8
0.8
no dnr
59
63
5.199219
69
24
35.79688
185
null
null
1.099854
145
7.359375
87
25
1,425
null
null
no(M2 and SIP pres)
4.081055
743
0
68.81598
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
12,606
8,449.125
9,210.875
24
white
36.296875
68
0.451965
0.332947
1
0
0
yes
null
null
no dnr
4
109
8.199219
50
24
36.29688
null
null
null
1.199951
136
null
97
23
4,050
null
null
<2 mo. follow-up
2.492676
4
1
78.85596
male
0
7
COPD
COPD/CHF/Cirrhosis
0
12
null
0
3,988
2,595.7773
2,477.75
2.5
white
13.298828
39
0.871948
0.787964
1
0
0
no
null
null
no dnr
7
72
8.398438
74
20
36.59375
null
3.799805
0.399963
1
140
null
76
9
8,600
null
null
null
2.612305
744
0
41.83197
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
28,393
18,363.4062
35,137.625
28
white
29.699219
44
0.779907
0.708984
3
0
0
no
0.5
0.5
no dnr
13
57
10.398438
167
24
35.89844
null
null
null
1
137
null
91
21
null
null
0
no(M2 and SIP pres)
0
742
0
70.97095
male
0
11
Lung Cancer
Cancer
3
12
$25-$50k
0
9,176
6,019.9141
6,357.51953
8
white
11.398438
31
0.792969
0.56189
1
0
0
metastatic
null
null
no dnr
11
74
13.199219
79
26
36.19531
183.3125
3.199707
0.399963
0.599976
141
7.439453
207
4
2,700
0
0
null
0
76
1
56.09
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
5
12
$25-$50k
0
11,949
8,494.4922
8,861.69531
19.5
white
26.296875
44
0.642944
0.461975
1
1
0
yes
0.3
0.2
no dnr
8
90
13.599609
69
28
36.19531
276
null
0.599976
0.799927
141
7.369141
242
20
3,300
0
0
no(M2 and SIP pres)
0
169
1
77.03796
female
0
5
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
3,384
2,219.3242
2,252.79883
8
white
16.898438
11
0.859985
0.767944
1
0
0
no
0.7
0.6
dnr after sadm
1
71
6.799805
101
28
35.79688
446.625
3.799805
0.299988
1.099854
136
7.319336
117
26
875
5
3
no(M2 and SIP pres)
3
723
0
71.28796
male
0
7
Lung Cancer
Cancer
2
12
null
0
4,495
2,965.0957
2,815.22852
6
white
25.296875
27
0.485962
0.166992
1
0
0
metastatic
0.25
0.1
dnr after sadm
1
101
9.898438
66
20
35.79688
347.5625
2.699707
0.199982
0.599976
128
7.459961
120
14
3,400
4
2
<2 mo. follow-up
2
26
1
56.33899
male
1
5
Coma
Coma
1
8
null
55
16,220
11,137.3359
12,067.9062
47
white
24.398438
36
0.453979
0.379944
4
1
0
no
0.5
0.5
dnr after sadm
5
100
31.398438
104
24
36.19531
319
null
null
0.899902
137
7.429688
168
21
3,800
null
null
<2 mo. follow-up
2.056152
5
1
31.22198
male
0
80
CHF
COPD/CHF/Cirrhosis
4
16
>$50k
0
100,714
64,004.9688
67,753.3125
15.25
white
24.597656
23
0.87793
0.796997
1
1
0
yes
0.5
0.25
no dnr
80
61
10.798828
58
15
36.79688
91.82812
null
1
0.899902
139
7.419922
163
11
2,685
0
0
no(M2 and SIP pres)
0
173
1
75.22198
female
0
22
CHF
COPD/CHF/Cirrhosis
3
8
null
0
16,569
10,865.5234
10,600.4453
12.666664
white
17.699219
34
0.855957
0.762939
1
1
0
no
null
null
no dnr
22
61
7.299805
100
24
39.39844
136
2
0.799927
10.099609
135
7.459961
188
72
null
null
null
null
2.820313
518
1
18.18999
female
0
21
Coma
Coma
0
11
null
94
49,598
32,209.9375
39,172.5
26
white
34
39
0.31897
0.246979
10
0
0
no
0.49
0.49
no dnr
21
117
16.699219
76
32
36
188
null
0.299988
0.799927
139
7.429688
183
16
1,625
null
0
no(M2 and SIP pres)
0
718
0
91.28796
female
1
5
CHF
COPD/CHF/Cirrhosis
3
10
$11-$25k
0
3,350
2,227.3711
2,336.53906
14
white
20.699219
39
0.754883
0.612915
1
0
0
no
null
null
dnr before sadm
-1
108
0.699951
156
22
36.69531
null
2.099609
1.299805
0.699951
132
null
122
8
2,750
null
null
<2 mo. follow-up
3.164551
5
1
33.09497
male
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
9,241
6,637.9531
7,612.96875
16
white
20.296875
18
0.906982
0.872925
3
0
0
no
0.95
0.95
no dnr
5
113
10.199219
59
28
38.79688
200
null
null
1.599854
137
7.479492
121
17
2,440
null
null
null
2.663574
717
0
30.69099
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
22,970
14,684.5781
16,134.2891
22
white
23.597656
12
0.885986
0.844971
3
0
0
no
0.95
0.95
no dnr
10
76
18.398438
72
26
36.39844
262.5
3.399902
0.5
0.699951
136
7.389648
102
9
2,700
1
0
null
0
717
0
82.60596
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
50,759
33,172.375
35,029.3438
47
white
34.5
58
0.359985
0.242981
30
0
0
no
0.2
0.2
dnr after sadm
5
105
9.099609
140
40
38.29688
194.28125
null
null
1.399902
140
7.339844
249
24
2,175
null
2
<2 mo. follow-up
2
5
1
69.90796
male
0
11
Lung Cancer
Cancer
1
null
null
0
14,305
9,534.0078
9,594.52344
8
white
15.398438
12
0.728882
0.45697
1
0
0
metastatic
0.5
0.3
dnr after sadm
4
65
8.298828
85
28
36.19531
320
null
null
1.399902
128
7.419922
140
58
null
2
0
no(M2 and SIP pres)
0
121
1
69.58795
female
0
32
CHF
COPD/CHF/Cirrhosis
4
12
null
0
29,039
19,057.5938
17,706.5156
10.5
white
11.398438
19
0.920898
0.866943
1
1
0
no
null
null
no dnr
32
77
11.199219
80
29
39
202.5
2.099609
0.399963
0.699951
129
7.469727
99
11
2,440
2
0
SIP>=30
0
712
0
68.19397
male
1
20
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
64,704
42,494.7812
49,044.5312
38
white
31.796875
55
0.651978
0.552979
1
0
0
no
0.3
0.25
no dnr
20
76
24.796875
72
28
39.09375
413.3125
2.199707
0.399963
1.199951
139
7.469727
209
36
2,250
null
6
<2 mo. follow-up
6
20
1
64.93396
male
0
4
Coma
Coma
1
10
null
100
7,978
null
null
46
white
24.097656
48
0.131989
0.084
1
0
0
yes
0.25
0.2
no dnr
4
50
18.898438
118
30
40
90
3
1.099854
1.5
136
7.389648
137
34
910
null
0
<2 mo. follow-up
0
7
1
81.88599
male
0
7
COPD
COPD/CHF/Cirrhosis
2
null
null
0
5,530
3,641.418
5,381.83984
4.5
white
16.796875
13
0.817993
0.704956
1
0
0
no
0.6
0.8
no dnr
7
115
7.899414
93
20
36.89844
null
3.599609
0.299988
1.299805
136
null
201
14
null
null
null
null
3.469727
710
0
64.24396
female
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
41
22,241
15,178.0938
17,272.4219
41
white
35
58
0.33197
0.21698
4
0
0
no
0.5
0.3
dnr after sadm
3
105
null
71
24
35.79688
280.9375
null
null
0.699951
137
7.379883
96
9
975
null
0
<2 mo. follow-up
0
6
1
51.01199
female
0
6
CHF
COPD/CHF/Cirrhosis
3
12
$25-$50k
0
5,990
4,180.5078
4,135.09766
16
white
15.398438
34
0.927979
0.876953
1
1
0
no
0.95
0.9
no dnr
6
60
10.5
148
32
36.39844
155
2.599609
0.399963
0.699951
141
7.389648
130
13
1,200
2
3
SIP>=30
3
706
0
78.32196
male
1
33
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
100
110,595
73,481.75
78,108.0625
46.5
white
25.398438
37
0.190979
0.100998
7
0
0
no
0.6
0.5
dnr after sadm
32
108
16.699219
126
46
39.39844
182.5
null
0.799927
1.399902
143
7.389648
204
21
2,100
null
2
<2 mo. follow-up
2
33
1
63.04999
female
0
18
Colon Cancer
Cancer
1
13
null
0
21,542
13,636.2188
13,912.6094
15
white
8.5
15
0.905884
0.781982
1
0
0
metastatic
0.95
0.9
no dnr
18
52
22.296875
76
6
36.19531
420
2.099609
0.699951
2.799805
147
7.369141
221
81
2,725
0
0
no(M2 and SIP pres)
0
124
1
66.95099
female
0
36
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
$25-$50k
41
125,149
84,051.8125
96,757
35
white
15.099609
38
0.760986
0.68396
21
1
0
no
0.75
0.6
dnr after sadm
2
101
12
66
20
36.39844
352.375
null
1.5
1.699951
138
7.479492
110
31
null
null
7
adl>=4 (>=5 if sur)
7
154
1
73.04895
female
0
9
COPD
COPD/CHF/Cirrhosis
3
12
under $11k
9
7,873
5,457.4727
5,522.97656
12
white
16.296875
13
0.850952
0.754883
1
1
0
no
0.9
0.8
no dnr
9
103
9.699219
74
22
36.79688
247.59375
2.699707
0.299988
0.799927
143
7.279297
158
8
null
0
1
no(M2 and SIP pres)
1
699
0
83.77295
female
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
$25-$50k
0
93,380
63,700.25
67,331.5625
47
white
58.398438
103
0.001
0
19
1
0
no
0
0
no dnr
3
109
8.298828
114
12
37.79688
null
1.799805
4.699219
0.599976
139
null
132
7
965
null
null
<2 mo. follow-up
2.87207
3
1
22.146
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
under $11k
0
29,891
19,014
21,844.5
23
white
16.398438
17
0.914917
0.883911
16
0
0
yes
0.7
0.7
no dnr
11
83
10.898438
76
18
36.79688
null
null
0.399963
1.099854
140
null
96
9
null
0
0
no(M2 and SIP pres)
0
698
0
68.06
female
0
3
Lung Cancer
Cancer
2
12
$11-$25k
0
4,051
2,550
1,565.18945
null
white
11.298828
19
0.799927
0.574951
1
0
0
metastatic
0.6
0.4
no dnr
3
51
12.398438
45
24
36.69531
217.375
3.599609
0.399963
1.299805
130
7.399414
211
23
1,700
null
0
no(M2 and SIP pres)
0
432
1
69.91895
male
0
6
CHF
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
4,386
2,976.1621
2,650.1582
14
white
19.097656
15
0.85791
0.764893
1
0
0
no
1
0.9
no dnr
6
72
3.899902
42
20
35.79688
null
4
0.399963
0.799927
138
null
144
12
3,250
0
null
no(M2 and SIP pres)
0.494751
697
0
78.21497
female
0
10
COPD
COPD/CHF/Cirrhosis
0
12
under $11k
0
6,278
4,128.7109
4,527.03906
8.5
white
20
31
0.794922
0.669922
1
0
0
no
0.8
0.6
dnr after sadm
1
84
null
67
20
36.19531
null
null
null
1.099854
136
null
110
13
null
5
3
SIP>=30
3
679
1
56.64899
male
1
9
MOSF w/Malig
ARF/MOSF
1
13
$25-$50k
9
64,165
39,395.8125
41,394.1875
32.5
white
31.699219
44
0.359985
0.242981
18
0
0
yes
0.8
0.7
no dnr
9
96
9.5
107
24
36.09375
280.9375
3.699707
1.399902
1.299805
142
7.479492
117
18
3,225
null
0
<2 mo. follow-up
0
9
1
74.85297
male
0
26
Coma
Coma
2
8
$25-$50k
100
26,893
18,100
16,823.4062
16.75
white
22.296875
39
0.161987
0.107986
1
0
0
no
0.04
0.04
no dnr
26
59
5.899414
76
30
35.79688
null
4.099609
2
2.699707
138
null
98
58
1,125
null
0
null
0
694
0
70.86096
female
0
9
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
8,175
5,472.7891
4,906.45703
8.5
white
17.699219
35
0.868896
0.782959
1
1
0
no
0.7
0.5
no dnr
9
127
6.099609
65
24
35.69531
419
null
0.199982
2.899902
140
7.429688
120
63
2,050
1
2
no(M2 and SIP pres)
2
370
1
84.85394
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
null
0
22,306
14,743.6094
14,665.6172
16.333328
white
31
37
0.572998
0.462952
1
0
0
no
0.8
0.8
no dnr
14
46
19.296875
105
10
39.39844
133.84375
3.199707
0.5
2.299805
133
7.339844
301
24
353
null
0
null
0
691
0
86.14899
male
1
10
Coma
Coma
1
10
null
100
15,476
9,943.0547
9,845.78906
27.5
white
22.398438
39
0.079987
0.044998
1
0
0
no
0.3
0.3
dnr after sadm
9
64
6.799805
114
24
36.19531
400
3.199707
0.899902
1.099854
138
7.509766
158
21
2,150
null
1
<2 mo. follow-up
1
10
1
91.33197
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
37
22,799
15,125.9453
15,507.0625
18.5
white
32.296875
52
0.305969
0.19397
1
0
0
no
null
null
dnr before sadm
-1
107
18.5
70
10
35.89844
207.5
4.199219
0.599976
0.699951
138
7.489258
254
23
1,790
null
0
SIP>=30
0
686
0
58.80099
female
0
69
COPD
COPD/CHF/Cirrhosis
7
11
null
0
140,005
99,652.9375
97,953.9375
40
white
31.398438
52
0.695923
0.530884
5
1
0
no
0.3
0.3
no dnr
69
72
11.199219
74
28
36.39844
106.65625
null
0.699951
1.099854
135
7.30957
178
36
null
null
6
SIP>=30
6
686
0
68.45398
male
0
65
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
26
94,981
58,759.7812
59,123.8438
25.75
white
32
50
0.225983
0.127991
3
0
0
metastatic
null
null
no dnr
65
76
20.398438
135
16
36.69531
null
null
null
1
138
null
90
10
2,600
0
0
SIP>=30
0
168
1
73.396
female
0
8
CHF
COPD/CHF/Cirrhosis
2
12
null
0
6,134
4,247.75
3,538.66992
4.5
white
17.597656
26
0.862915
0.773926
1
0
0
no
null
null
dnr after sadm
2
101
10.398438
96
24
36.29688
null
3.599609
0.699951
1.699951
135
null
260
17
1,900
2
0
no(M2 and SIP pres)
0
377
1
41.88898
female
0
5
Lung Cancer
Cancer
1
13
null
0
7,325
5,001.2109
4,844.12891
4
white
16.5
11
0.767944
0.518921
1
0
0
metastatic
null
null
no dnr
5
70
8.5
62
20
37.69531
null
null
null
0.899902
138
null
84
11
null
0
1
no(M2 and SIP pres)
1
504
1